Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency

Authors: Anna M. Zhang, MD, Ahmed Elmoursi, MD, MPH, Daniel V. DiGiacomo, MD, MPH, Baijun Zhou, MHS, Megha Tandon, BA, Joseph S. Hong, BS, Nancy J. Yang, BS, Mei-Sing Ong, PhD, Anand S. Dighe, MD, PhD, Cristhian Berrios, MD, Mark C. Poznansky, MD, PhD, Anthony J. Iafrate, MD, PhD, Vivek Naranbhai, PhD, MB, ChB, Alejandro Balazs, PhD, Shiv Pillai, MBBS, PhD, Jocelyn R. Farmer, MD, PhD, Sara Barmettler, MD

Source: Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100234- (2024)

Subject Terms: Predominantly antibody deficiency, SARS-CoV-2, common variable immunodeficiency, anti-spike antibody, Omicron BA.5 variant, neutralization, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2772829324000304; https://doaj.org/toc/2772-8293

Access URL: https://doaj.org/article/fb70345af39d40f2a59af24a8a4fa4a0